secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cingulate Inc. (CING)
CIK:        0001862150
Form:       8-K
Filed at:   2023-08-01T23:59:59+00:00
Accession:  0001493152-23-026158
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Cingulate receives Nasdaq bid price deficiency notice; equity compliance extension to Nov 13, 2023
--------------------------------------------------------------------------------

- On July 28, 2023, Nasdaq granted extension until Nov 13, 2023 to regain minimum stockholders' equity of $2.5M, conditioned on capital raise.
- Same day, Nasdaq notified Cingulate of non-compliance with $1.00 minimum bid price; 180-day cure period until Jan 24, 2024.
- If equity not compliant by Nov 13 or bid price not compliant by Jan 24, securities subject to delisting from Nasdaq.
- Company considering options including reverse stock split to regain bid price compliance.
- Delisting could harm capital access and liquidity; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1862150/000149315223026158/0001493152-23-026158-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1862150/000149315223026158/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-026158

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer